Ancora Heart has reached the first enrollment milestone in the CORCINCH-HF pivotal trial of the AccuCinch® System in patients with heart failure.

Understand how MRI-derived RV strain predicts outcomes in HFpEF, offering improved risk stratification over traditional ...

Ancora Heart announced it has reached the first enrollment milestone in its CORCINCH-HF pivotal trial evaluating the ...

CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease: Bagsværd, Denmark Wednesday, June 25, 2025, 15:00 Hrs [IST] Novo Nordisk, a leading global h ...

DREAMS-2: A Phase 3 study comparing mazdutide and dulaglutide in Chinese T2D patients with inadequate glycemic control on ...

Two biotech innovators launched products that solve challenges in gene therapy scale-up and learn from omics data from ...

Guided by the motto, "Start with Integrity, Succeed through Action," Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry ...

PARAGON-HF in included patients with left ventricular ejection fraction (LVEF) of 45% or more, but earlier studies have suggested the drug can have a benefit in people with scores below 40%.

Watch the online edition of Global News Hour at 6 BC. ‘It was a bigger response than I could’ve dreamed of and I am so grateful for everyone’s support,’ friend and wedding organizer ...

Find the latest stock market news from every corner of the globe at Reuters.com, your online source for breaking international market and finance news ...

billboard global excl. us the week's most popular songs based on streaming and sales activity from over 200 territories around the world — excluding the united states — as tracked by luminate.